by Jon C. Ogg
(AAPL) Apple noted as Cramer’s #2 Growth Stock for 2007.
(AINV) Apollo Investment fell 1.5% after filing to sell 16 million shares.
(ANGO) AngioDynamics positive in Business Week.
(BAMM) Books-a-Million fell another 1.5% after falling 3% Thursday after beating revenues but posting lower s-s-s for December.
(BBY) Best Buy trading up 4% pre-market on 15% revenue rise and domestic s-s-s up 6.1% for the quarter.
(BJRI) BJ’s Restaurants rose 1% after beating revenue expectations for the quarter.
(BMRN) BioMarin starts Phase II studies in peripheral artery disease.
(CPST) Capstone Turbine received $1.6 million in a follow-on order out of Russia.
(CSCO) Cisco Systems noted as Cramer’s #3 Growth Stock for 2007.
(DLTR) Dollar Tree traded up marginally after essentially reaffirming sales targets.
(DNA) Genentech reported Positive Phase II Pertusumab results after the close.
(GM) GM said it won’t lose #1 title to Toyota without a fight.
(HWAY) Healthways traded down 5% after reporting mixed earnings and revenue slightly under plan.
(INWK) InnerWorkings filed to sell 8 million shares, 5 million are from holders.
(MCRL) Micrel lowered guidance.
(MEDI) Medimmune noted as being worth $45 in takeover potentially according to Business Week article.
(MOT) Motorola trading down 5% after warning.
(MRVL) Marvell Tech said it is raising some executive stock option exercise prices after option reviews.
(NYT) New York Times is selling its broadcasting division for $575 Million to focus on papers.
(NYX) NYSE noted as Cramer’s #1 Growth Stock for 2007.
(OPWV) Openwave traded down 5% after issuing anotherearnings warning for this quarter and next; company also announced it plans to waste up to $100M of shareholder money in share repurchases.
(RBAK) Redback lowered guidance, but this is under tender by Ericsson since December.
(RMBS) Rambus terminated former CEO’s outstanding stock options.
(RNOW) Rightnow Tech fell 12% after signalling a loss instead of break-even results.
(SABA) Saba Software traded up almost 5% after exceeding earnings estimates.
(SYNP) Synplicity shares traded down 27% after lowering guidance.
(TASR) Taser is launching new personal protection product at CES next week.
(TWTR) Tweeter fell more than 2% after announcing it missed sales expectations.
(XRTX) Xyratex fell about 3% after beating lowered guidance, fell because warned for next quarter.